Thallion Pharmaceuticals’ novel anti-cancer drug which offers two modes of action – ECO-4601 – showed positive results from its Phase I/II clinical trial.
According to Pierre Falardeau, Ph.D., chief operating officer at Thallion Pharmaceuticals in Montreal, Canada:
”In 26 patients with advanced solid tumors, treatment with ECO-4601 is safe and well tolerated, including at doses yielding plasma concentrations above the expected therapeutic threshold.
ECO-4601 has a unique mechanism of action comprising two distinct activities. It inhibits the RAS/MAPK intracellular signaling pathway, which is mutated in many cancer types, and which is the target of several approved cancer drugs such as Erbitux, Avastin, Tarceva, …read more

It has already been said that phytochemicals from cruciferous vegetables like broccoli, cauliflower and the likes have strong anti-cancer properties. Even pregnant women by eating these veggies will help protect their unborn children from developing cancer later in their adult life.
However, it seems like new wonders in broccoli keep getting discovered, probably to give us another reason to eat our vegetables and hopefully to convince our children to love eating them too.
Personally, I do love broccolis (and cauliflowers too!). Unfortunately, they aren’t always available in markets where I live. But on few occasions that they are, I make sure we …read more